Detalhe da pesquisa
1.
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Ann Oncol
; 34(7): 615-625, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105265
2.
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Ann Oncol
; 31(11): 1506-1517, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891793
3.
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Ann Oncol
; 29(3): 758-765, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216400
4.
Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
Ann Oncol
; 28(11): 2813-2819, 2017 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045520
5.
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
Ann Oncol
; 28(3): 541-546, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426120
6.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 28(12): 3000-3008, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950372
7.
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Gynecol Oncol
; 142(1): 89-94, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27012429
8.
RANK/OPG ratio of expression in primary clear-cell renal cell carcinoma is associated with bone metastasis and prognosis in patients treated with anti-VEGFR-TKIs.
Br J Cancer
; 113(9): 1313-22, 2015 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26528707
9.
Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma.
Br J Cancer
; 113(1): 12-9, 2015 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26086878
10.
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials.
Ann Oncol
; 26(2): 422-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403589
11.
Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Ann Oncol
; 26(3): 598-607, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488684
12.
Resolution of diffuse skin and systemic Kaposi's sarcoma in a renal transplant recipient after introduction of everolimus: a case report.
Transpl Infect Dis
; 17(2): 303-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25645490
13.
Single-centre 20-year experience with surgical treatment of thymic tumours.
Acta Chir Belg
; 115: 52-61, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26021792
14.
Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database.
Ann Oncol
; 25(6): 1222-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24608201
15.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 30(2): 344, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29741569
16.
Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib.
Br J Cancer
; 108(4): 887-900, 2013 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23462807
17.
MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours.
Br J Cancer
; 109(6): 1625-35, 2013 Sep 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-23969726
18.
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
Ann Oncol
; 24(6): 1513-25, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23396606
19.
Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.
Ann Oncol
; 24(2): 537-542, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23117071
20.
Phase I study of pulsatile 3-day administration of afatinib (BIBW 2992) in combination with docetaxel in advanced solid tumors.
Invest New Drugs
; 31(3): 734-41, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23161334